Nucleotide-based Pathogen Treatment Systems for Water, Agriculture, and Surfaces
Legal Citation
Summary of the Inventive Concept
This inventive concept expands the application of nucleotide and nucleoside compositions to treat waterborne pathogens, agricultural pathogens, and surface pathogens, leveraging the core technology of the original patent to address critical problems in these new fields.
Background and Problem Solved
The original patent disclosed pharmaceutical compositions comprising substituted nucleotides and nucleosides for treating viral infections. However, the growing concern about waterborne, agricultural, and surface pathogens necessitates innovative solutions. The new inventive concept addresses these pressing issues by adapting the core technology to develop nucleotide-based treatment systems for these new applications.
Detailed Description of the Inventive Concept
The inventive concept involves the use of nucleotide or nucleoside compositions of Formula Im, wherein R1 is:, R2 is alkyl or cycloalkyl, and R3 is aryl, wherein the aryl is optionally substituted with one or more substituents. These compositions can be applied to water treatment systems to reduce the concentration of waterborne pathogens, to crops to reduce the concentration of agricultural pathogens, or to surfaces to reduce the concentration of pathogens. The compositions can be prepared using various methods, including conjugation with amino acid esters, lipids, or sphingolipids, and can be formulated with pharmaceutically acceptable excipients.
Novelty and Inventive Step
The new claims introduce a novel application of the nucleotide and nucleoside compositions, extending their use beyond pharmaceutical compositions for treating viral infections to treating waterborne, agricultural, and surface pathogens. The inventive step lies in the recognition of the potential of these compositions to address critical problems in these new fields and the adaptation of the core technology to develop effective treatment systems.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different nucleotide or nucleoside compositions, varying the type and amount of substituents, or modifying the formulation to enhance efficacy or stability. Additionally, the treatment systems could be integrated with existing infrastructure, such as water treatment plants or agricultural irrigation systems, to enhance their effectiveness.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the water treatment, agriculture, and surface disinfection industries, where the need for effective pathogen treatment solutions is pressing. The market for these solutions is substantial, with potential applications in municipal water treatment, agricultural crop protection, and surface disinfection for healthcare and food processing facilities.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical chemistry, specifically nucleotide and nucleoside composition design for pathogen treatment, with expertise in molecular conjugation, formulation techniques, and application strategies across biological systems
Person of Ordinary Skill (PHOSITA) Profile
A PhD-level researcher with advanced training in organic chemistry, molecular biology, and pharmaceutical sciences, capable of understanding complex molecular structures, designing chemical variations, and evaluating potential applications across different treatment domains
Obviousness Rationale
A PHOSITA would recognize that the fundamental nucleotide composition from the source patent provides a versatile molecular platform that can be readily adapted to different pathogen treatment contexts. The core chemical structure remains substantially unchanged, with the primary innovation being the expanded application domains of water, agricultural, and surface pathogen treatment. The molecular mechanisms of nucleotide interactions with biological systems suggest predictable efficacy across different environmental contexts.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,560 |
|---|---|
| Title | Pharmaceutical compositions comprising substituted nucleotides and nucleosides for treating viral infections |
| Assignee(s) | Emory University |